Pfizer Inc
Pfizer RSV vaccine that protects infants could receive FDA approval this summer
David Paul Morris | Bloomberg | Getty Images Pfizer‘s vaccine that protects infants from respiratory syncytial virus could receive Food and Drug Administration approval by the end of this summer. Pfizer on Tuesday said the FDA is reviewing the vaccine on an expedited basis. The agency is expected to make a decision on whether to […]
Read More
Eli Lilly recruits Black patients for Alzheimer trial as drugmakers seek more diversity in clinical studies
Sharon Kimbrough went to the Black Women’s Expo in Atlanta to sell her memoir. Getting tested for Alzheimer’s was the furthest thing on her mind, but when nurses from Eli Lilly approached her about the company’s new trial, she decided to let them draw her blood. “I had two family members that had Alzheimer’s,” said […]
Read More
U.S. plans to stop buying Covid shots for the public this fall. Here’s what that means
A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store in October. Antonio Perez | Tribune News Service | Getty Images The U.S. will stop buying Covid shots at reduced price for the entire country and shift vaccine distribution to the private market as soon as early fall, shifting the cost to U.S. […]
Read More
The Covid pandemic drives Pfizer’s 2022 revenue to a record $100 billion
Empty vials of Pfizer-BioNTech coronavirus disease (COVID-19) children’s vaccines are pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., May 19, 2022. Hannah Beier | Reuters The ongoing Covid-19 pandemic propelled pharmaceutical company Pfizer’s earnings to a record $100 billion last year, almost $57 billion of which was driven by its vaccine and antiviral pill Paxlovid, […]
Read More
The end of the Covid health emergency won’t slow FDA clearance of shots and treatments
Vials and a medical syringe seen displayed in front of the Food and Drug Administration (FDA) of the United States logo. FDA finds the COVID-19 vaccine. Pavlo Gonchar | LightRocket | Getty Images The Food and Drug Administration on Tuesday said its emergency authorizations of Covid vaccines, tests and treatments will not be impacted by […]
Read More
Pfizer expects 2023 sales to decline as much as 33% compared with record-breaking 2022
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Pfizer on Tuesday issued sales guidance of $67 billion to $71 billion for 2023, a decline from its record-breaking 2022 results. The pharmaceutical company booked […]
Read More
Stocks making the biggest moves premarket: McDonald’s, UPS, General Motors and more
In this article IP XOM GM CAT Follow your favorite stocksCREATE FREE ACCOUNT Nathan Stirk | Getty Images News | Getty Images Check out the companies making headlines before the bell. McDonald’s — Shares dipped more than 1% after McDonald’s reported its latest quarterly results. The fast food giant topped earnings and revenue estimates, saying […]
Read More
FDA doesn’t see increased risk of stroke for seniors who received Pfizer’s omicron booster
A nurses fills up syringes for patients as they receive their coronavirus disease (COVID-19) booster vaccination during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, September 29, 2021. Emily Elconin | Reuters The Food and Drug Administration hasn’t found an increased risk of stroke for seniors who’ve received Pfizer’s omicron booster shot, a federal health official […]
Read More
Omicron booster shots provide some protection against mild illness from Covid XBB subvariants, CDC says
Pfizer‘s and Moderna‘s omicron boosters reduced the risk of mild illness from the XBB family of subvariants compared to people who did not receive the shot, according to a study from the Centers for Disease Control and Prevention published Wednesday. The CDC study provides the first estimate of the omicron shots’ real-world effectiveness against the […]
Read More
Moderna, Pfizer’s new race: The RSV vaccine Food and drug administration approval process
The Covid vaccine is below to continue to be following a development method that broke the history publications at both of those Moderna and Pfizer, but a new golden age ofvaccines may perhaps only be at its beginning. The two companies have produced results from RSV vaccine trials with efficacy benefits strong more than enough […]
Read More